GlassScriptPhysician profile
George Clements
NPI 1780078600
$1,359.43
in general payments reported to CMS, 2019-2025
21 companies · $82.21 in 2025
The $82.21 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $352 · 2022: $664 · 2023: $94.82 · 2024: $167 · 2025: $82.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $272.34 | 2022-2025 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $158.80 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $138.35 | 2022 | |
| Amgen INC. | $119.47 | 2021-2022 | |
| Medtronic, INC. | $105.92 | 2024 | Corevalve Evolut R |
| Pfizer INC. | $102.69 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.90 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $53.91 | 2021-2022 | |
| Esperion Therapeutics, INC. | $42.62 | 2021 | |
| Philips North America LLC | $39.26 | 2022-2025 | Ecc Solutions |
| Astrazeneca Pharmaceuticals LP | $35.14 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $32.97 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $29.95 | 2022 | |
| Novo Nordisk INC | $29.17 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.55 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.29 | 2022 | |
| Chiesi USA, INC. | $21.49 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $19.89 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $19.01 | 2021 | |
| Amryt Pharma Holdings LTD | $14.74 | 2021 | |
| Tactile Systems Technology INC | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Clements listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.